Clinical Trials Directory

Trials / Completed

CompletedNCT04655326

Probiotic Therapy for Children and Adults With Autism Spectrum Disorder

Assessment of Customized Probiotic Therapy for Children and Adults With Autism Spectrum Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
296 (actual)
Sponsor
Arizona State University · Academic / Other
Sex
All
Age
30 Months – 75 Years
Healthy volunteers
Not accepted

Summary

This is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.

Detailed description

SunGenomics provides its customers with a customized probiotic based on an analysis of the microbiota in their stool samples. Customers who have autism spectrum disorders are invited to participate in this study by completing several questionnaires about their medical history, diet, autism symptoms, and gastrointestinal symptoms before taking the probiotic, and to repeat those questionnaires approximately 3 months later. This is effectively an open-label study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFlorepersonalized blend of GRAS approved probiotic strains, prebiotics, and botanicals

Timeline

Start date
2020-10-15
Primary completion
2025-05-15
Completion
2025-07-12
First posted
2020-12-07
Last updated
2026-04-09
Results posted
2026-04-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04655326. Inclusion in this directory is not an endorsement.